{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:08:53Z","timestamp":1785863333123,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04176-0","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T15:06:12Z","timestamp":1738508772000},"page":"553-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Etiology, presentation, and outcomes of hyperprolactinemia due to pituitary masses in children and adolescents"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-7908","authenticated-orcid":false,"given":"Fatih","family":"Kilci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-5408","authenticated-orcid":false,"given":"Emre","family":"Sarikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-8012","authenticated-orcid":false,"given":"Nurhan \u00d6zcan","family":"Murat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-3787","authenticated-orcid":false,"given":"Adnan","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"4176_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1515\/jpem-2012-0130","volume":"25","author":"G Catli","year":"2012","unstructured":"G. Catli, A. Abaci, A. Altincik et al. Hyperprolactinemia in children: clinical features and long-term results. J. Pediatr. Endocrinol. Metab. 25, 1123\u20131128 (2012). https:\/\/doi.org\/10.1515\/jpem-2012-0130","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"4176_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2015.36","volume":"11","author":"V Bernard","year":"2015","unstructured":"V. Bernard, J. Young, P. Chanson, N. Binart, New insights in prolactin: pathological implications. Nat. Rev. Endocrinol. 11, 265\u2013275 (2015). https:\/\/doi.org\/10.1038\/nrendo.2015.36","journal-title":"Nat. Rev. Endocrinol."},{"key":"4176_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00431-018-3074-1","volume":"177","author":"A Hoffmann","year":"2018","unstructured":"A. Hoffmann, S. Adelmann, K. Lohle, A. Claviez, H.L. M\u00fcller, Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis. Eur. J. Pediatr. 177, 125\u2013132 (2018). https:\/\/doi.org\/10.1007\/s00431-018-3074-1","journal-title":"Eur. J. Pediatr."},{"key":"4176_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000284359","volume":"73","author":"L Saranac","year":"2010","unstructured":"L. Saranac, S. Zivanovic, Z. Radovanovic, G. Kostic, I. Markovic, P. Miljkovic, Hyperprolactinemia: different clinical expression in childhood. Horm. Res. Paediatr. 73, 187\u2013192 (2010). https:\/\/doi.org\/10.1159\/000284359","journal-title":"Horm. Res. Paediatr."},{"issue":"7","key":"4176_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/s-0035-1550018","volume":"123","author":"R Stawerska","year":"2015","unstructured":"R Stawerska, J Smyczy\u0144ska, M Hilczer, A Lewi\u0144ski, Does elevated morning prolactin concentration in children always mean the diagnosis of hyperprolactinemia? Exp. Clin. Endocrinol. Diabetes 123(7), 405\u2013410 (2015). https:\/\/doi.org\/10.1055\/s-0035-1550018.","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"1","key":"4176_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000499694","volume":"109","author":"L Vilar","year":"2019","unstructured":"L Vilar, C.F Vilar, R Lyra, M.D.C Freitas, Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology 109(1), 7\u201319 (2019). https:\/\/doi.org\/10.1159\/000499694.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"4176_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.20945\/2359-39970000000270","volume":"62","author":"L Vilar","year":"2018","unstructured":"L Vilar, J Abucham, J.L Albuquerque, et al., Controversial issues in the management of hyperprolactinemia and prolactinomas - an overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Arch. Endocrinol. Metab. 62(2), 236\u2013263 (2018). https:\/\/doi.org\/10.20945\/2359-39970000000270.","journal-title":"Arch. Endocrinol. Metab."},{"key":"4176_CR8","doi-asserted-by":"crossref","unstructured":"M.D. Bronstein. Disorders of prolactin secretion and prolactinomas. In Endocrinology. 6th ed. ed. L.J. DeGroot, J.L. Jameson. (Saunders\/Elsevier: Philadelphia, 2010), pp. 333-357.","DOI":"10.1016\/B978-1-4160-5583-9.00018-6"},{"issue":"2","key":"4176_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4274\/jcrpe.galenos.2018.2018.0206","volume":"11","author":"E Eren","year":"2019","unstructured":"E Eren, A T\u00f6rel Erg\u00fcr, \u015e.P \u0130\u015fg\u00fcven, et al., Clinical and laboratory characteristics of hyperprolactinemia in children and adolescents: national survey. J. Clin. Res. Pediatr. Endocrinol. 11(2), 149\u2013156 (2019). https:\/\/doi.org\/10.4274\/jcrpe.galenos.2018.2018.0206.","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"Suppl 1","key":"4176_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0306-4530(02)00112-9","volume":"28","author":"U Halbreich","year":"2003","unstructured":"U Halbreich, B.J Kinon, J.A Gilmore, L.S Kahn, Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 28(Suppl 1), 53\u201367 (2003). https:\/\/doi.org\/10.1016\/s0306-4530(02)00112-9.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"4176_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12020-009-9279-7","volume":"37","author":"JW Hong","year":"2010","unstructured":"J.W Hong, M.K Lee, S.H Kim, E.J Lee, Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma. Endocrine 37(1), 140\u2013147 (2010). https:\/\/doi.org\/10.1007\/s12020-009-9279-7.","journal-title":"Endocrine"},{"issue":"1","key":"4176_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"S.L Asa, O Mete, A Perry, R.Y Osamura, Overview of the 2022 WHO classification of pituitary tumors. Endocr. Pathol. 33(1), 6\u201326 (2022).","journal-title":"Endocr. Pathol."},{"key":"4176_CR13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.4158\/EP15938.DSC","volume":"21","author":"SL Samson","year":"2015","unstructured":"S.L. Samson, A.H. Hamrahian, S. Ezzat; AACE Neuroendocrine and Pituitary Scientific Committee; American College of Endocrinology (ACE), American association of clinical endocrinologists, american college of endocrinology disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr. Pract. 21, 1427\u20131435 (2015)","journal-title":"Endocr. Pract."},{"issue":"10058","key":"4176_CR14","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","volume":"388","author":"CE Higham","year":"2016","unstructured":"C.E Higham, G Johannsson, S.M Shalet, Hypopituitarism. Lancet 388(10058), 2403\u20132415 (2016). https:\/\/doi.org\/10.1016\/S0140-6736(16)30053-8.","journal-title":"Lancet"},{"key":"4176_CR15","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"L Katznelson, E.R LawsJr, S Melmed, M.E Molitch, M.H Murad, A Utz, J.A. Wass, Endocrine Society, Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933\u20133951 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4176_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4274\/jcrpe.2183","volume":"7","author":"O Neyzi","year":"2015","unstructured":"O. Neyzi, R. Bundak, G. G\u00f6k\u00e7ay et al. Reference values for weight, height, head circumference, and body mass index in Turkish children. J. Clin. Res. Pediatr. Endocrinol. 7, 280\u2013293 (2015). https:\/\/doi.org\/10.4274\/jcrpe.2183","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"5","key":"4176_CR17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.24953\/turkjped.2021.4639","volume":"64","author":"T Kontbay","year":"2022","unstructured":"T Kontbay, Z \u015e\u0131klar, E \u00d6zsu, et al., Hyperprolactinemia in children and adolescents and long-term follow-up results of prolactinoma cases: a single-centre experience. Turk. J. Pediatr. 64(5), 892\u2013899 (2022). https:\/\/doi.org\/10.24953\/turkjped.2021.4639.","journal-title":"Turk. J. Pediatr."},{"issue":"3","key":"4176_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11102-008-0115-9","volume":"12","author":"SV Acharya","year":"2009","unstructured":"S.V Acharya, R.A Gopal, T.R Bandgar, et al., Clinical profile and long-term follow-up of children and adolescents with prolactinomas. Pituitary 12(3), 186\u2013189 (2009). https:\/\/doi.org\/10.1007\/s11102-008-0115-9.","journal-title":"Pituitary"},{"issue":"3","key":"4176_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/jpem.2000.13.3.261","volume":"13","author":"HL Fideleff","year":"2000","unstructured":"H.L Fideleff, H.R Boquete, A Sequera, et al., Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. J. Pediatr. Endocrinol. Metab. 13(3), 261\u2013267 (2000). https:\/\/doi.org\/10.1515\/jpem.2000.13.3.261.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"4176_CR20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jc.2014-3597","volume":"100","author":"S Salenave","year":"2015","unstructured":"S. Salenave, D. Ancelle, T. Bahougne et al. Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J. Clin. Endocrinol. Metab. 100, 1177\u20131186 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3597","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4176_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12020-023-03523-3","volume":"83","author":"F Kilci","year":"2024","unstructured":"F Kilci, J.H Jones, M \u00c7akl\u0131l\u0131, et al., Clinical and therapeutic outcomes of pediatric pituitary adenomas: a single pituitary center experience. Endocrine 83(1), 160\u2013170 (2024). https:\/\/doi.org\/10.1007\/s12020-023-03523-3.","journal-title":"Endocrine"},{"key":"4176_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fendo.2020.00527","volume":"11","author":"A Yang","year":"2020","unstructured":"A. Yang, S.Y. Cho, H. Park et al. Clinical, hormonal, and neuroradiological characteristics and therapeutic outcomes of prolactinomas in children and adolescents at a single center. Front. Endocrinol. 11, 527 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.00527","journal-title":"Front. Endocrinol."},{"issue":"3","key":"4176_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/cen.14394","volume":"94","author":"VB Arya","year":"2021","unstructured":"V.B Arya, S.J.B Aylwin, T Hulse, et al., Prolactinoma in childhood and adolescence: tumor size at presentation predicts management strategy: single centre series and a systematic review and meta-analysis. Clin. Endocrinol. 94(3), 413\u2013423 (2021). https:\/\/doi.org\/10.1111\/cen.14394.","journal-title":"Clin. Endocrinol."},{"key":"4176_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"S. Melmed, F.F. Casanueva, A.R. Hoffman et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 273\u2013288 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4176_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00865-y","volume":"19","author":"S Petersenn","year":"2023","unstructured":"S. Petersenn, M. Fleseriu, F.F. Casanueva et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement. Nat. Rev. Endocrinol. 19, 722\u2013740 (2023). https:\/\/doi.org\/10.1038\/s41574-023-00865-y","journal-title":"Nat. Rev. Endocrinol."},{"key":"4176_CR26","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMcp0912025","volume":"362","author":"A Klibanski","year":"2010","unstructured":"A. Klibanski, Clinical practice. prolactinomas. N. Engl. J. Med. 362, 1219\u20131226 (2010). https:\/\/doi.org\/10.1056\/NEJMcp0912025","journal-title":"N. Engl. J. Med."},{"key":"4176_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s40618-016-0483-z","volume":"39","author":"E Sala","year":"2016","unstructured":"E. Sala, P. Bellaviti Buttoni, E. Malchiodi, E. Verrua, G. Carosi, E. Profka et al. Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas. J. Endocrinol. Invest. 39, 1377\u20131382 (2016). https:\/\/doi.org\/10.1007\/s40618-016-0483-z","journal-title":"J. Endocrinol. Invest."},{"key":"4176_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-2265.2011.04136.x","volume":"75","author":"TM Barber","year":"2011","unstructured":"T.M. Barber, J. Kenkre, C. Garnett, R.V. Scott, J.V. Byrne, J.A.H. Wass, Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma. Clin. Endocrinol. 75, 819\u2013824 (2011). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04136.x","journal-title":"Clin. Endocrinol."},{"key":"4176_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.endonu.2012.11.005","volume":"60","author":"I Halperin Rabinovich","year":"2013","unstructured":"I. Halperin Rabinovich, R. Camara Gomez, M. Garcia Mouriz, D. Ollero Garcia-Agullo; Grupo de Trabajo de Neuroendocrinologia de la S, Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia. Endocrinol. Nutr. 60, 308\u2013319 (2013). https:\/\/doi.org\/10.1016\/j.endonu.2012.11.005","journal-title":"Endocrinol. Nutr."},{"issue":"3","key":"4176_CR30","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1096\/fj.201902357R","volume":"34","author":"F Lopez-Vicchi","year":"2020","unstructured":"F Lopez-Vicchi, S.R Ladyman, A.M Ornstein, P Gustafson, P Knowles, G.M Luque, et al., Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake. FASEB J. 34(3), 3902\u20133914 (2020). https:\/\/doi.org\/10.1096\/fj.201902357R.","journal-title":"FASEB J."},{"key":"4176_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.883092","volume":"13","author":"F Lopez-Vicchi","year":"2022","unstructured":"F. Lopez-Vicchi, C. De Winne, A.M. Ornstein, E. Sorianello, J. Toneatto, D. Becu-Villalobos, Severe hyperprolactinemia promotes brown adipose tissue whitening and aggravates high fat diet induced metabolic imbalance. Front. Endocrinol. 13, 883092 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.883092","journal-title":"Front. Endocrinol."},{"key":"4176_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/eje.0.1470077","volume":"147","author":"M Doknic","year":"2002","unstructured":"M. Doknic, S. Pekic, M. Zarkovic, M. Medic-Stojanoska, C. Dieguez, F. Casanueva et al. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur. J. Endocrinol. 147, 77\u201384 (2002). https:\/\/doi.org\/10.1530\/eje.0.1470077","journal-title":"Eur. J. Endocrinol."},{"key":"4176_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1758-5996-6-104","volume":"6","author":"M Ezrokhi","year":"2014","unstructured":"M. Ezrokhi, S. Luo, Y. Trubitsyna, A.H. Cincotta, Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats. Diabetol. Metab. Syndr. 6, 104 (2014). https:\/\/doi.org\/10.1186\/1758-5996-6-104","journal-title":"Diabetol. Metab. Syndr."},{"key":"4176_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1285477","volume":"14","author":"L Wang","year":"2023","unstructured":"L. Wang, X. Wang, F. Gong, H. Pan, H. Zhu, Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. Front. Endocrinol. 14, 1285477 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1285477","journal-title":"Front. Endocrinol."},{"issue":"3","key":"4176_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11102-005-1757-1","volume":"7","author":"PF Day","year":"2004","unstructured":"P.F Day, M Guitelman, R Artese, L Fiszledjer, A Chervin, N.M Vitale, et al., Retrospective multicentric study of pituitary incidentalomas [published correction appears in Pituitary. 14(2):198\u2013198. (2011)]. Pituitary 7(3), 145\u2013148 (2004).","journal-title":"Pituitary"},{"issue":"5","key":"4176_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/BF03346388","volume":"31","author":"L Vilar","year":"2008","unstructured":"L Vilar, M.C Freitas, L.A Naves, L.A Casulari, M Azevedo, et al., Diagnosis and management of hyperprolactinemia: results of a Brazilian Multicenter Study with 1234 patients. J. Endocrinol. Invest. 31(5), 436\u2013444 (2008).","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"4176_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","volume":"65","author":"N Karavitaki","year":"2006","unstructured":"N Karavitaki, G Thanabalasingham, H.C Shore, R Trifanescu, O Ansorge, N Meston, et al., Do the limits of serum prolactin in disconnection hyperprolactinaemia need redefinition? a study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin. Endocrinol. 65(4), 524\u2013529 (2006).","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"4176_CR38","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1210\/jc.2019-01252","volume":"104","author":"VV Thaker","year":"2019","unstructured":"V.V Thaker, A.E Lage, G Kumari, V.M Silvera, L.E Cohen, Clinical Course of Nonfunctional Pituitary Microadenoma in Children: A Single-Center Experience. J. Clin. Endocrinol. Metab. 104(12), 5906\u20135912 (2019). https:\/\/doi.org\/10.1210\/jc.2019-01252.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4176_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4274\/jcrpe.galenos.2024.2024-1-3","volume":"16","author":"Z \u015e\u0131klar","year":"2024","unstructured":"Z \u015e\u0131klar, E \u00d6zsu, S K\u0131z\u0131lcan \u00c7etin, et al., Comprehensive insights into pediatric craniopharyngioma: endocrine and metabolic profiles, treatment challenges, and long-term outcomes from a Multicenter Study. J. Clin. Res. Pediatr. Endocrinol. 16(3), 288\u2013296 (2024). https:\/\/doi.org\/10.4274\/jcrpe.galenos.2024.2024-1-3.","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"4176_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000481633","volume":"89","author":"T Breil","year":"2018","unstructured":"T. Breil, C. Lorz, D. Choukair, J. Mittnacht, I. Inta, D. Klose et al. Clinical features and response to treatment of prolactinomas in children and adolescents: a retrospective single-centre analysis and review of the literature. Horm. Res. Paediatr. 89, 157\u2013165 (2018). https:\/\/doi.org\/10.1159\/000481633","journal-title":"Horm. Res. Paediatr."},{"issue":"4","key":"4176_CR41","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"P.U Freda, A.M Beckers, L Katznelson, M.E Molitch, V.M Montori, K.D Post, et al., Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(4), 894\u2013904 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4176_CR42","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1210\/jcem.85.5.6611","volume":"85","author":"BM Arafah","year":"2000","unstructured":"B.M Arafah, D Prunty, J Ybarra, M.L Hlavin, W.R Selman, The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J. Clin. Endocrinol. Metab. 85(5), 1789\u20131793 (2000). https:\/\/doi.org\/10.1210\/jcem.85.5.6611.","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4176_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cen.12860","volume":"83","author":"AH Sam","year":"2015","unstructured":"A.H Sam, S Shah, K Saleh, et al., Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively. Clin. Endocrinol. 83(6), 861\u2013865 (2015). https:\/\/doi.org\/10.1111\/cen.12860.","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"4176_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.445","volume":"6","author":"V Guerreiro","year":"2023","unstructured":"V Guerreiro, F Mendon\u00e7a, H Urbano Ferreira, et al., Incidental versus symptomatic nonfunctioning pituitary adenomas: are they different? Endocrinol. Diabetes Metab. 6(6), e445 (2023). https:\/\/doi.org\/10.1002\/edm2.445.","journal-title":"Endocrinol. Diabetes Metab."},{"issue":"2","key":"4176_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1742-1241.2010.02537.x","volume":"65","author":"P Anagnostis","year":"2011","unstructured":"P Anagnostis, F Adamidou, S.A Polyzos, Z Efstathiadou, A Panagiotou, M Kita, Pituitary incidentalomas: a single-centre experience. Int. J. Clin. Pract. 65(2), 172\u2013177 (2011). https:\/\/doi.org\/10.1111\/j.1742-1241.2010.02537.x.","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"4176_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ejendo\/lvad070","volume":"189","author":"R Hamblin","year":"2023","unstructured":"R Hamblin, A Fountas, K Lithgow, et al., Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium. Eur. J. Endocrinol. 189(1), 87\u201395 (2023). https:\/\/doi.org\/10.1093\/ejendo\/lvad070.","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"4176_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101440","volume":"34","author":"G Patti","year":"2020","unstructured":"G Patti, A Ibba, G Morana, et al., Central diabetes insipidus in children: diagnosis and management. Best. Pract. Res. Clin. Endocrinol. Metab. 34(5), 101440 (2020). https:\/\/doi.org\/10.1016\/j.beem.2020.101440.","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"4176_CR48","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1210\/clinem\/dgac747","volume":"108","author":"L Das","year":"2023","unstructured":"L Das, P Dutta, Approach to the patient: a case with an unusual cause of hypopituitarism. J. Clin. Endocrinol. Metab. 108(6), 1488\u20131504 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgac747.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04176-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04176-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04176-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:47:23Z","timestamp":1747036043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04176-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04176-0","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,2]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Kocaeli City Hospital Ethics Committee (approval number: 2024\/107).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}